Categories for Treatment


Hope for Stage IV Cancer Patients through Precision Oncology

Published by on April 18, 2018 | Share your thoughts

Is precision oncology really that much better than conventional cancer care? The answer is, Yes! And here are the statistics to prove it. In the following graph and tables, we outline the overall significant increase in survival rates that our patients experience in contrast to those seen with conventional/standard Canadian cancer care.  Live Longer with Precision Oncology The patients listed have had at least one or more of CTOAM’s recommended therapies. Additionally, the patient data used for this chart comes from clients who were all determined to be stage IV at the time they reached out to bring us on board. It is possible, if not probably, that patients may have been at stage IV for a significant period of time before CTOAM’s involvement, and...
Read Article


New Treatment for Glioblastoma – How an Innovative Drug Combo is Saving Lives

Published by on April 5, 2018 | Share your thoughts

New research has found that the addition of tumour-treating fields to temozolomide maintenance improved progression-free survival (PFS) and overall survival (OS) in glioblastoma patients.   New Treatment for Glioblastoma: Addition of Tumour-Treating Fields to Maintenance Temozolomide in Glioblastoma Glioblastoma is one of the most difficult types of cancer to treat. However, treatments are continuing to improve as new precision oncology research emerges. About TTFields: Tumour-treating fields (TTFields) consist of low-intensity, alternating electric fields that are delivered by transducer arrays applied to the scalp. The tumour-treating fields modality interferes with glioblastoma cell division and organelle assembly by delivery of low-intensity alternating electric fields to the tumour. Therefore, researchers were interested in discovering whether adding TTFields to maintenance temozolomide chemotherapy would improve PFS and OS rates for...
Read Article